A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
- Status
- RECRUITING
- Phase
- PHASE2
Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Two Implementation Strategies for the Collection of Electronic Patient-Reported Outcomes Among Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma
- Status
- RECRUITING
- Phase
- N/A
Real-World Mapping Antithrombotic Regimens in MM Patients on Treatment
- Status
- RECRUITING
- Phase
- N/A
Self-administration of Subcutaneous Elranatamab in the Patients' Homes.
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Prospective Cohort of Single-dose Radiotherapy for Painful Bone Lesions in Multiple Myeloma
- Status
- RECRUITING
- Phase
- NA
Cyclin D1 as a Prognostic Factor in Multiple Myeloma and Its Association With the Immunological Prognostic Factor PDL1 and Clinical and Biochemical Lab Tests
- Status
- UNKNOWN
- Phase
- NA
Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
- Status
- RECRUITING
- Phase
- N/A
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Providing Cancer Care Closer to Home for Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- NA
Helical Tomotherapy in Multiple Myeloma
- Status
- RECRUITING
- Phase
- NA